Delivery Order HDTRA112D0003-0019

Award Date 10/31/16
Potential Completion Date 9/30/22
Potential Value $4.6M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $523,200.00 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD), doing business as the Defence Science and Technology Laboratory (DSTL), located in the United Kingdom. The contract is for basic research to support DTRA and Department of Homeland Security efforts to counter chemical, biological, radiological, and nuclear threats. Past MOD contracts have included developing medical countermeasures, diagnostic...
This is a federal contract award to the Ministry of Defence (MOD), doing business as D S T L, located in Great Britain, United Kingdom. The contract, valued at $4,385,034.00, is a Delivery Order contract with a Cost Plus Fixed Fee pricing type, awarded by the Defense Threat Reduction Agency (DTRA) for "ANTHRAX DETECTION - BASE" efforts. The contract has no set-aside designation. Based on the vendor's past performance, the work likely involves research and development services...
The U.S. Defense Threat Reduction Agency (DTRA) awarded a $9,005,780.36 Cost Plus Fixed Fee contract to the Ministry of Defence (MOD) of the United Kingdom, doing business as the Defence Science and Technology Laboratory (DSTL), for the development of non-ionic surfactant vesicles (NISVs) as drug delivery and targeting systems for antimicrobials. This contract, which has no set-aside designation, supports DTRA's research and development efforts to counter chemical, biological, radiological,...
The Defense Threat Reduction Agency (DTRA) awarded a $1.1 million cost-plus-fixed-fee delivery order contract to the Ministry of Defence, doing business as DSTL, for work under its AD92 program. To be performed in Great Britain from December 2015 through March 2018, this contract calls for DSTL to provide unspecified services to DTRA in support of the agency's counter-weapons-of-mass-destruction efforts. As the prime contractor, DSTL will leverage its expertise conducting scientific research...
The U.S. Defense Threat Reduction Agency awarded a $1,573,426.25 cost-plus-fixed-fee contract to the Ministry of Defence, doing business as DSTL, a UK government entity. The contract is for the "Biological Agent Diagnostic Lexicon for Clinical Information Exploitation", with a completion date of December 15, 2022. This contract supports research and development efforts by U.S. defense and homeland security agencies to counter emerging biological and chemical threats, including...
This is a $1,189,718.74 cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence, doing business as DSTL, located in Great Britain, United Kingdom. The contract is for pharmacological and biologic interventions to reduce inflammation and seizures caused by viral encephalitis. This contract was awarded under a Broad Agency Announcement (BAA) from DTRA that sought proposals for various chemical and biological defense technology...
This is a cost-plus-fixed-fee definitive contract awarded by the Defense Threat Reduction Agency to the Ministry of Defence, doing business as D S T L, a U.K. government entity. The contract, valued at $2,758,080.00, is for a project titled "Harnessing Natural Regulators to Combat Anti-Microbial Resistance (AMR)". The contract has no set-aside designation. The work supports U.S. defense and homeland security efforts to counter emerging biological and chemical threats, through...
This is a $775,339.30 cost-plus-fixed-fee definitive contract awarded to the Ministry of Defence (operating as D S T L), a government entity in the United Kingdom, by the U.S. Army's Research, Development and Engineering Command. The contract is for the STRIDER ENHANCEMENT program, and does not have a set-aside designation. Based on D S T L's past federal contract work, the contract likely involves research and development services related to countering chemical, biological, radiological, and...
The Department of Homeland Security Science and Technology Directorate awarded a $1.922 million other transaction agreement to the Ministry of Defence, doing business as D S T L, located in Great Britain, United Kingdom. This contract is to support the Directorate's Innovative Research Call 2020 program through June 2025. Under the agreement, D S T L will provide research and development services to advance the Science and Technology Directorate's mission to deliver effective and relevant...
This is a cost-plus-fixed-fee delivery order awarded to the Ministry of Defence, doing business as DSTL, a government entity in the United Kingdom. The $2,382,706.00 contract was awarded on June 29, 2016 by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, for animal model development services. The contract has an ultimate completion date of October 31, 2019 and is a task order under the larger BARDA Animal Model Development 2011-2016 multiple-award IDIQ...
  • HDTRA112D0003
    Indefinite Delivery Contract
  • HDTRA112D0003-0019
    Delivery Order

This is a federal contract award from the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, doing business as the Defence Science and Technology Laboratory (DSTL). The contract, with a ceiling value of $4,636,158.00, is for a base period ending on September 30, 2022. It is a cost-plus-fixed-fee delivery order contract with no set-aside designation.

The MOD/DSTL has been awarded this contract to provide research and development services focused on countering chemical, biological, radiological, and nuclear threats. This includes developing medical countermeasures, diagnostic tools, conducting fundamental research, and building decision support systems. The work supports DTRA and the Department of Homeland Security Science and Technology Directorate's efforts to address emerging biological and chemical threats.

Generated 4/2/25, 4:52 PM